Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2004;13(Supplement 1 ):i48-i56; doi:10.1136/tc.2002.002816
Copyright © 2004 by the BMJ Publishing Group Ltd.
Tobacco Control 2004;13:i48
© 2004 BMJ Publishing Group Ltd

RESEARCH PAPER

Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke

S S Hecht

Correspondence to:
Correspondence to:
Professor Stephen S Hecht
University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, MN 55455, USA; hecht002{at}umn.edu

Objective: To review the literature on carcinogen derived biomarkers of exposure to secondhand tobacco smoke (SHS). These biomarkers are specifically related to known carcinogens in tobacco smoke and include urinary metabolites, DNA adducts, and blood protein adducts.

Method: Published reviews and the current literature were searched for relevant articles.

Results: The most consistently elevated biomarker in people exposed to SHS was 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-Gluc), urinary metabolites of the tobacco specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). The tobacco specificity of this biomarker as well as its clear relation to an established lung carcinogen are particularly appropriate for its application in studies of SHS exposure.

Conclusion: The results of the available carcinogen derived biomarker studies provide biochemical data which support the conclusion, based on epidemiologic investigations, that SHS causes lung cancer in non-smokers.

Keywords: secondhand smoke; carcinogens; biomarkers

Abbreviations: 8-OH-dG, 8-hydroxydeoxyguanosine; BaP, benzo[a]pyrene; GC-MS, gas chromatography-mass spectrometry; HPB, 4-hydroxy-1-(3-pyridyl)-1-butanone; IARC, International Agency for Research on Cancer; NNAL, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N'-nitrosonornicotine; PAH, polycyclic aromatic hydrocarbons; SHS, secondhand smoke; SS, sidestream smoke; ttMA, trans,trans-muconic acid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Church, T. R., Anderson, K. E., Caporaso, N. E., Geisser, M. S., Le, C. T., Zhang, Y., Benoit, A. R., Carmella, S. G., Hecht, S. S. (2009). A Prospectively Measured Serum Biomarker for a Tobacco-Specific Carcinogen and Lung Cancer in Smokers. Cancer Epidemiol. Biomarkers Prev. 18: 260-266 [Abstract] [Full Text]  
  • Leslie, E. M., Ghibellini, G., Nezasa, K.-i., Brouwer, K. L.R. (2007). Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats. Carcinogenesis 28: 2650-2656 [Abstract] [Full Text]  
  • Schick, S. F., Glantz, S. (2007). Concentrations of the Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Sidestream Cigarette Smoke Increase after Release into Indoor Air: Results from Unpublished Tobacco Industry Research. Cancer Epidemiol. Biomarkers Prev. 16: 1547-1553 [Abstract] [Full Text]  
  • Granville, C. A., Warfel, N., Tsurutani, J., Hollander, M. C., Robertson, M., Fox, S. D., Veenstra, T. D., Issaq, H. J., Linnoila, R. I., Dennis, P. A. (2007). Identification of a Highly Effective Rapamycin Schedule that Markedly Reduces the Size, Multiplicity, and Phenotypic Progression of Tobacco Carcinogen-Induced Murine Lung Tumors. Clin. Cancer Res. 13: 2281-2289 [Abstract] [Full Text]  
  • Ginzel, K. H., Maritz, G. S., Marks, D. F., Neuberger, M., Pauly, Jim. R., Polito, J. R., Schulte-Hermann, R., Slotkin, T. A. (2007). Critical Review: Nicotine for the Fetus, the Infant and the Adolescent?. J Health Psychol 12: 215-224 [Abstract]  
  • Hatsukami, D. K., Le, C. T., Zhang, Y., Joseph, A. M., Mooney, M. E., Carmella, S. G., Hecht, S. S. (2006). Toxicant Exposure in Cigarette Reducers versus Light Smokers. Cancer Epidemiol. Biomarkers Prev. 15: 2355-2358 [Abstract] [Full Text]  
  • Airoldi, L., Vineis, P., Colombi, A., Olgiati, L., Dell'Osta, C., Fanelli, R., Manzi, L., Veglia, F., Autrup, H., Dunning, A., Garte, S., Hainaut, P., Hoek, G., Krzyzanowski, M., Malaveille, C., Matullo, G., Overvad, K., Tjonneland, A., Clavel-Chapelon, F., Linseisen, J., Boeing, H., Trichopoulou, A., Palli, D., Peluso, M., Krogh, V., Tumino, R., Panico, S., Bueno-De-Mesquita, H. B., Peeters, P. H., Lund, E., Agudo, A., Martinez, C., Dorronsoro, M., Barricarte, A., Chirlaque, M. D., Quiros, J. R., Berglund, G., Jarvholm, B., Hallmans, G., Day, N. E., Allen, N., Saracci, R., Kaaks, R., Riboli, E. (2005). 4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study. Cancer Epidemiol. Biomarkers Prev. 14: 2118-2124 [Abstract] [Full Text]  
  • Tulunay, O. E., Hecht, S. S., Carmella, S. G., Zhang, Y., Lemmonds, C., Murphy, S., Hatsukami, D. K. (2005). Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers. Cancer Epidemiol. Biomarkers Prev. 14: 1283-1286 [Abstract] [Full Text]  
  • Richmond, J B, Burns, D M, Cummings, K M (2004). Public health and the power of individual action. Tobacco Control 13: i1-2 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.